Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05476458
Other study ID # RDIH-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 15, 2022
Est. completion date July 1, 2023

Study information

Verified date May 2023
Source Asian Institute of Gastroenterology, India
Contact Dr Pradev Inavolu, MBBS
Phone 9963088053
Email pradev32@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Peroral endoscopic myotomy (POEM) is a novel endoscopic technique for the treatment of achalasia and other esophageal motility disorders. Initially, it was introduced to the world by Inoue et al. in 2008.7 Thereafter; it was rapidly disseminated because of low invasiveness, higher efficacy and technical novelty. The steps of performing POEM include mucosal incision, submucosal tunnel creation, myotomy and closure of the incision. Mucosotomy (2.8%) is the most common adverse event in patients undergoing POEM.8 It can be due to excessive use of cautery because bleeding points could not be seen clearly with white light during active ooze. RDI will help in early recognition of the bleeding points, thus prompt hemostasis. Bleeding during POEM is not very uncommon(0.5-0.7%).9 Early recognition of bleeding points and quicker hemosasis help in decreasing complications. The utility of RDI in the peroral endoscopic myotomy is not studied so far to our knowledge. Hence in this study we would like to look into the utility of red dichromatic imaging in per-oral endoscopic myotomy.


Description:

After obtaining departmental and ethics committee clearance, study will be conducted in AIG Hospitals, Hyderabad. Written informed consent will be taken from the patient or relative before enrolling into the study. After enrolment, participants were allocated into Red dichromatic imaging group(Group 1) and White light imaging group(Group 2). All patients will undergo endoscopy prior to the procedure. All the procedures in this study will be performed by single endoscopic trainee, previously performed less than ten procedures. Red Dichromatic Imaging (RDI) works by employing green, amber and red wavelength. - Green light (520-550nm) - Amber (595-610nm) - Red Light (620-640nm) Group 1: Per-oral endoscopic myotomy will be performed using novel Evis X1 endoscopy(Olympus corporation, Tokyo, Japan) system. RDI mode 1 and Mode 2 will be used during the procedure. Submucosal bleb will be created by injecting mixture of indigo carmine and normal saline. RDI mode 2 will be used for submucosal injection and Mucosal incision. RDI Mode 2 helps in detection of deep mucosal or submucosal vessels which are the major cause of bleeding. Submucosal dissection and myotomy will be performed under white light. However when there is bleeding, RDI mode 1 will be used for the detection of bleeding point. Bleeding will be controlled with spray coagulation or using Coagrasper. Hemostasis treatment will be performed by switching to RDI only at the time of bleeding during the procedure. Group 2: Per-oral endoscopic myotomy will be performed using CV-190 Gastroscope (Olympus corporation, Tokyo, Japan). White light imaging is used during entire procedure. Submucosal bleb will be created by injecting mixture of indigo carmine and normal saline. Initial submucosal injection and Mucosal incision will be performed under white light. RDI Entry point bleed and ease of entry into the tunnel will be marked by trainee at the end of the procedure. Submucosal dissection and myotomy will be performed under white light. When there is bleeding, bleeding point is identified with white light and hemostasis is achieved.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date July 1, 2023
Est. primary completion date July 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - • Consecutive consenting patients of both gender posted for POEM in the department of Medical Gastroenterology, AIG Hospitals. Exclusion Criteria: - • Patients aged under 18 years of age - Unable to provide informed consent - Inherited or acquired coagulopathy likely to affect the risk of bleeding - Receiving anticoagulant therapy that could not be stopped or bridged prior to procedure - Breast feeding, pregnant and lactating women's

Study Design


Intervention

Radiation:
White Light Imaging
white light imaging is often the preferred option for poem surgery due to its effective results. However, it also comes with some drawbacks that make it difficult to identify areas of bleeding, unlike RDI, WLI cannot enhance the visibility of deep vessels This can lead to longer haemostasis time as the physician must wait for a longer period before stopping the bleeding. This can make it challenging as it may lead to excessive bleeding. This makes RDI a potential solution for those seeking a more accurate approach to treatment.
Red Light Imaging
Red dichromatic imaging (RDI) is a next-generation image enhancement technique which works by employing green, amber and red wavelengths. Greenlight(520-550nm) can visualize small blood vessels in superficial tissue without extending deep into the mucosa. Amber(595-610nm) and red light (620-640nm) can penetrate deep into the tissue owing to low scattering property. The blood vessels in the deeper tissues absorb the amber light because of strong affinity with hemoglobin. Even though red light can penetrate deep into the tissue, it is weakly absorbed by hemoglobin. Hence the reflected light contains red light and amber light without attenuation.

Locations

Country Name City State
India Aig Hospitals Hyderabad Telangana
India Asian Institute of Gastroenterology Hyderabad Telangana

Sponsors (1)

Lead Sponsor Collaborator
Asian Institute of Gastroenterology, India

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the change in total procedural time using Red dichromatic imaging (RDI) compared to white light imaging in achieving haemostasis during POEM To determine the change in total procedural time using Red dichromatic imaging (RDI) compared to white light imaging in achieving haemostasis during POEM To determine the change in total procedural time using Red dichromatic imaging (RDI) compared to white light imaging in achieving haemostasis during POEM
Secondary To identify avascular mucosal site by identifying and avoiding deep blood vessels using RDI after 1 month and 6 month Psychological stress experienced by endoscopists during haemostasis treatment as assessed on a scale of 1-5 (1) no stress. (2) minor stress (3) moderate stress (4) high stress (5) very high stress, Ease of mucosal entry by using RDI when compared to white light imaging. Use of RDI in comparison with white light imaging in achieving haemostasis (haemostasis time) after 1 month and 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05775731 - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Recruiting NCT04600609 - Examining the Experiences of Children With Blood Disorders
Active, not recruiting NCT04309084 - Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma Phase 1
Completed NCT04757285 - Copeptin and Psychological Stress of Medic During COVID-19 Pandemic
Terminated NCT04729946 - Clinical and Urgent Colonoscopy Outcomes Using the Pure-Vu® Cleansing System N/A
Not yet recruiting NCT06242353 - Coagulopathy in Childhood Acute Lymphoblastic Leukaemia
Completed NCT04499612 - Influence of Cardiac Implantable Electronic Devices on the Hemostatic System
Not yet recruiting NCT06328647 - Quantra Point-of-Care Hemostasis Monitoring N/A
Not yet recruiting NCT04179357 - Hemostatic Disorders on Intensive Care Patients.
Recruiting NCT04650529 - Gyeongsang National University Hospital Registry
Completed NCT03756948 - Viscoelastic Tests-Guided Therapy In Liver Transplantation N/A
Recruiting NCT04762576 - Thrombin in Cardiac Surgery
Completed NCT03555383 - Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP)
Terminated NCT03806556 - A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia Phase 1/Phase 2
Recruiting NCT03281252 - A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in China N/A